Home Compare HEI vs NBIX
Stock Comparison · Single-driver result

HEICO vs Neurocrine Biosciences: Which Stock Looks Stronger in 2026?

The structural profiles are close, with HEICO carrying a narrow edge on profitability. Neurocrine Biosciences still leads on growth and valuation, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in profitability, while growth remains the main counterforce.

Trajectory Similarity
0.71
Similar
Peer-set rank: #3
within HEICO Corporation's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

The strongest overlap appears in investment intensity and operating margin level.

Similarity drivers
investment intensityoperating margin level
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
HEI
HEICO Corporation
57
Peer-Score
Signal qualityHigh
vs
NBIX
Neurocrine Biosciences, Inc.
56
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: HEI vs NBIX Profitability 89 32 Stability 54 47 Valuation 41 63 Growth 38 88 HEI NBIX
Gap Ranking
#1 Profitability +57
#2 Growth +50
#3 Valuation +22
#4 Stability +7
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for HEI and NBIX Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer HEINBIX Relative valuation Structural strength

Neurocrine Biosciences, Inc. and HEICO Corporation look relatively close on structure, but the price setup still leans toward Neurocrine Biosciences, Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, HEICO Corporation ranks near the top of the group; Neurocrine Biosciences, Inc. sits in the weaker half.
Growth
The same broad pattern appears on growth: Neurocrine Biosciences, Inc. ranks near the top of the group, while HEICO Corporation stays in the weaker half.
Profitability — Dominant Gap
HEI
89
NBIX
32
Gap+57in favour of HEI

The clearest distance comes from a stronger profitability profile.

What keeps the gap from being one-sided

Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

The main read on profitability is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the HEI vs NBIX comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how HEI and NBIX each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.